Initial studies had reported leukemia incidences in children treated with GH replacement in Japan (294, 295); however, later follow-up studies were unsuccessful in establishing a link between GH therapy and leukemia when patients with existing risk factors were excluded (296). This evidence concerns the gene GH1 and leukemia.